Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Fibromyalgia
NCT01653457Phase 3Unknown
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- Sep 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Memantine with Placebo (2 arms). Primary endpoints: Change from baseline in pain threshold at 6 months and Change from baseline in pain perception at 6 months. Status: unknown.
02
Drugs
memantine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01653457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01653457.